Buscar

Estamos realizando la búsqueda. Por favor, espere...

Subcutaneous (SC) Isatuximab (Isa) administration by an On-Body Delivery System (OBDS) in combination with Pomalidomide-Dexamethasone (Pd) in Relapsed/Refractory Multiple Myeloma (RRMM) patients: interim phase 1b study results

Autoría

QUACH, HANG

PARMAR, GURDEEP

ORIOL, ALBERT

TSUKADA, NOBUHIRO

SUNAMI, KAZUTAKA

BORIES, PIERRE

KARANES, CHATCHADA

MADAN, SUMIT

SEMIOND, DOROTHEE

INCHAUSPE, MARLENE

MACÉ, SANDRINE

SUZAN, FLORENCE

MOREAU, PHILIPPE